Stanford University: Depressive Disorder, Major trials
The registry lists 38 Depressive Disorder, Major studies with Stanford University as lead sponsor. 9 are open to participants now and 13 have results posted.
Phase 1 1Phase 2 4Phase 3 3Phase 4 4No phase 27(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant DepressionNot yet recruitingNCT07528157Not applicable
- Study of Psilocybin Under Anesthesia Controlled by EEGNot yet recruitingNCT07479550Phase 2
- Optimizing Brain Excitability in DepressionRecruitingNCT07242105Not applicable
- Virtual Reality-Enhanced Behavioral Activation for Older Adults With DepressionRecruitingNCT07188623Not applicable
- Sleep TMS for DepressionRecruitingNCT06824415Not applicable
- Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingNot yet recruitingNCT06748950Not applicable
- Sedation and Guided Education for Depression StudyNot yet recruitingNCT06705270Not applicable
- Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in HumansRecruitingNCT05996900Not applicable
- Treatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMSRecruitingNCT04870255Not applicable
- Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in DepressionCompletedNCT05224063Not applicableResults posted
- Virtual Reality Behavioral Activation: An Intervention for Major Depressive DisorderCompletedNCT04268316Not applicableResults posted
- The BIomarker Guided (BIG) Study for DepressionCompletedNCT04181736Phase 4Results posted
- Closed-loop Optimized rTMS for DepressionCompletedNCT04142320Phase 1Results posted
- Opiate Suicide Study in Patients With Major DepressionCompletedNCT04116528Phase 3Results posted
- Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac SurgeryCompletedNCT03861988Phase 4Results posted
- Brain Imaging of rTMS Treatment for DepressionCompletedNCT01829165Not applicableResults posted
- Pioglitazone in Patients With Mood DisordersCompletedNCT01559857Phase 4Results posted
- Treatment of Schizoaffective Disorder Using MifepristoneTerminatedNCT00725270Phase 2/3Results posted
- Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECTCompletedNCT00285818Not applicableResults posted
- Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major DepressionCompletedNCT00186498Not applicableResults posted
- Treatment of Nicotine Dependence and Acute DepressionCompletedNCT00186446Phase 4Results posted
- Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression OutcomeCompletedNCT00149825Phase 2Results posted
- Behavioral and Neuronal Correlates of Human Mood StatesCompletedNCT06159595Not applicable
- Extended Reality Behavioral Activation: An Intervention for Major Depressive DisorderCompletedNCT05525390Not applicable
- Rapid Acting TMS for Suicide Ideation in DepressionWithdrawnNCT05100004Not applicable
- Treatment for Cognitive Impairment in DepressionWithdrawnNCT04317001Phase 3
- rTMS Study in Depression to Evaluate the Relationship Between Brain Plasticity and Clinical OutcomeWithdrawnNCT04032015Not applicable
- Accelerated Intermittent Theta-Burst Stimulation for Opiate Use DisorderWithdrawnNCT03804619Not applicable
- MRS and Medication Response: A Pilot StudyTerminatedNCT03254342
- Brain-Based Biomarkers in Response to TMS in MDDCompletedNCT02843373
- Identifying Biological Markers for Severe DepressionCompletedNCT01831882
- Investigate Efficacy & Safety of RO4995819 vs. Placebo as Adjunct Tx in Patients w/Major Depressive DisorderWithdrawnNCT01733654Phase 2
- Mothers With a History of Depression and Their 10-14 Year Old DaughtersCompletedNCT01129752
- Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
- Genetics of Symptomatology and Treatment Response in Psychotic Major DepressionCompletedNCT00691535
- Clinical and Biological Characteristics of Psychotic DepressionCompletedNCT00576095
- Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major DepressionCompletedNCT00285727Not applicable
- Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?CompletedNCT00186264Not applicable